Medicinal plants are remarkable because of their ability to produce a vast number of secondary metabolites. The genus Neonauclea belongs to the family Rubiaceae, subfamily Cinchonoideae, tribe Naucleeae, and is native to South-East Asia, especially the Malaysian region [1] . However, there is no scientific information available about the bioactive compounds present in Neonauclea purpurea. The National Centre for Natural Science and Technology of Vietnam has provided preliminary data about the biological assay of crude alkaloid extracts with low cytotoxicity (3% inhibition at 10 μg ml -1 ). Therefore, in this study, we focus on identifying the constituents of the bark of N. purpurea by bioassay-guided fractionation. We report the results of antimicrobial testing against Candida albicans, Stapphylococcus epidermidis, Staphylococcus aureus, Bacillus cereus, and B. subtilis. In addition, we measured the antimalarial activity against Plasmodium falciparum (K1 strain) and cytotoxicity against monkey (Vero) cells.
From the methanol extract of N. purpurea, after fractionation and column chromatographic separation, three compounds were isolated, which were identified from spectroscopic and mass spectrometric data as cadambine [2, 4] , α-dihydrocadambine [2] [3] [4] , and 2,6-dimethoxy-1,4-benzoquinone (2,6-DMBQ) [5] . This is the first report of these compounds in N. purpurea. The alkaloids cadambine and α-dihydrocadambine have so far been reported only from the family Rubiaceae. The cadambine content of N. purpurea (61 µg g -1 DW) was found to be 11 times higher than that of Uncaria rhynchophylla (5.23 µg g -1 DW) [6] , while the αdihydrocadambine content of N. purpurea (88 µg g -1 DW) was found to be 28 and 4.4 times higher than that in U. rhynchophylla (3.13 µg g -1 DW) and A. chinensis (20 µg g -1 DW), respectively [6, 7] . The antimalarial activities of α-dihydrocadambine and 2,6-DMBQ were measured using dihydroartemisinin (IC 50 = 3.6 nM) as the reference compound. The result showed activity with IC 50 values of 3.59 µg ml -1 (65.68 nM) and 1.90 µg ml -1 (113.1 nM), respectively. Cadambine was found to be inactive (<50% inhibition).
The cytotoxicities of cadambine, α-dihydrocadambine, and 2,6-DMBQ were tested against Vero cells using final concentrations of 50 μg ml -1 of each compound. Ellipticine, with IC 50 = 0.5 ± 0.2 μg ml -1 , was used as the positive control. Only 2,6-DMBQ showed cytotoxicity with IC 50 = 0.2 µg ml -1 , whereas cadambine and α-dihydrocadambine showed low cytotoxicities with IC 50 > 50 μg ml -1 . Cadambine, α-dihydrocadambine, and 2,6-DMBQ were tested for MIC 90 against bacteria and yeast by using a mixture of methylparaben and propylparaben (MP: 5:4) as the positive control (Table 1 ). MIC 90 value of 2,6-DMBQ showed a highly significant difference from that of the other two compounds and the positive control, for all tested organisms.
Compound 3 has been detected previously in at least 27 plant families [8] . However, this is the first report on the extraction of 2,6-DMBQ from N. purpurea. Furthermore, the quantity of 2,6-DMBQ detected in the bark of N. purpurea (0.02 mg g -1 DW) was 40 times higher than that reported in the rhizomes of Gynura japonica (0.49 µg g -1 DW) by Lin et al. (2003) [9] . 2,6-DMBQ detected in the bark of N. purpurea was initially characterized as a cytotoxin and was studied for its use as a plant-derived antitumor agent but was later recognized to be an antimicrobial agent and antiplatelet aggregation agent as well [5, 8] . 2,6-DMBQ extracted from the rhizomes of G. japonica showed total inhibition of platelet aggregation at a concentration of 50 μg ml -1 in the presence of a platelet aggregation inducer [9] . Purified 2,6-DMBQ showed antimicrobial activity seven to nine times higher than that of the positive control (MP) against Gram-positive bacteria. It also showed 24 times higher activity against the yeast C. albicans than The minimum inhibitory concentrations of the purified compounds extracted from the bark of N. purpurea, which were tested against different microbes. 1/ The methylparaben/propylparaben ratio in the mixture is 5:4. Different letters within the column indicate the highly significant difference of mean (±SD) determined by Duncan's multiple range test (DMRT) at p ≤ 0.01. The data were analyzed from three replications of each treatment. did the positive control. Because of its high antimicrobial activity, 2,6-DMBQ can be used as a preservative in cosmetics. Since 2,6-DMBQ can be obtained easily by the enzymatic oxidation of phenolic acids, it can be chemically synthesized on an industrial scale. 2,6-DMBQ can also be used as a chemical in the study of the cell to cell function in plants, since it has been reported as the first natural fungal-haustorium-inducing factor in the roots of host plants. 2,6-DMBQ is released into the rhizosphere as root exudates [10] . It would be interesting to investigate the effect of 2,6-DMBQ on the inhibition of Agrobacterium infection in plant tissues during T-DNA transformation because this compound may act as a signal enhancer between the bacterial vir gene and the host plants. This would reveal the possibility of using 2,6-DMBQ as a vir-inducing compound, similar to acetosyringone (4'-hydroxy-3,5dimethoxyacetophenone), to promote the transformation efficiency of Ti-plasmids.
The result of the chemical analysis and biological assays in this study provide a scientific basis for the use of N. purpurea bark as a traditional medicine to cure fever in Vietnam. N. purpurea (genus Neonauclea) bark contains three bioactive compounds with antibacterial activity that have not been previously reported from the genus Neonauclea, despite the fact that N. purpurea is included in the family Rubiaceae, which includes other medicinal plants as well. 
Experimental

Extraction and purification:
The methanolic extract of N. purpurea (103.51 g) was re-extracted by the acid/base separation and partition sequentially with CH 2 Cl 2 and n-BuOH to yield 10.18 g and 24.1 g respectively. The bioactive compound in n-BuOH fraction was fractionated by column chromatography to obtained compound 1 (0.061 mg.g -1 DW) and compound 2 (0.088 mg.g -1 DW). As well as CH 2 Cl 2 fraction contain compound 3 (0.02 mg.g -1 DW).
Bioassay:
The antimalarial activities were tested with Plasmodium falciparum (K1, multi-drug resistant strain) using dihydroartemisinin (DHA) as standard compound and measured by microculture radioisotope technique described by Desjardins (1979) [11] . Minimun inhibitory concentrations were tested for their MIC 90 against Gram + bacteria and yeast by following the method of The National Committee for Clinical Laboratory Standards (NCCLS). Moreover, the cytotoxicity was determined by colorimetric method [12] .
